ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina

ClinicalTrials.gov ID: NCT04976777

Public ClinicalTrials.gov record NCT04976777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 5:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of an Updated Dexamethasone Posterior Segment Drug Delivery System Applicator in Participants With Macular Edema Due to Retinal Diseases

Study identification

NCT ID
NCT04976777
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
54 participants

Conditions and interventions

Conditions

Interventions

  • Approved DEX PS DDS Applicator Device
  • Dexamethasone Drug
  • Updated DEX PS DDS Applicator Device

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2021
Primary completion
Feb 8, 2022
Completion
Feb 8, 2022
Last update posted
Feb 27, 2023

2021 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Global Research Management /ID# 238944 Glendale California 91204-2500
Advanced Eye Centers Inc /ID# 233429 North Dartmouth Massachusetts 02747-1278
Discover Vision Centers /ID# 239366 Independence Missouri 64055-6974
Charleston Neurosciences Institute /ID# 238521 Charleston South Carolina 29414-5896
Retina Research Institute of Texas /ID# 231420 Abilene Texas 79606-1224
Texas Retina Associates /ID# 231305 Arlington Texas 76012
North Texas Retina Consultants /ID# 241013 Willow Park Texas 76087-9133

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04976777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2023 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04976777 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →